1155029

Novartis Gene Therapies, Inc. — FEI 3014617030

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 27, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Diego, CA (United States)